Search for
Menu
About
Overview
Impact
Partners
Team
Programs
Entrepreneurs
Corporates
Industries
Internship Program
Innovation Center
Mentors
Capital
Rev1 Capital
Funds
Rev1 Spark Grant
Portfolio
Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Home
Entrepreneurs
Rev1 Labs
Corporates
Capital
Portfolio
About
Team
Events
Jobs
Blog
Get Started
Search for
Merlin Therapeutics Awarded Maximum Amount Under NIH STTR Grant to Develop Gene Therapy for Neurofibromatosis Type 2 (NF2)
By
Giselle Planchart
on
09/30/2024
Merlin Therapeutics Awarded Maximum Amount Under NIH STTR Grant to Develop Gene Therapy for Neurofibromatosis Type 2 (NF2)
Merlin Therapeutics Awarded Maximum Amount Under NIH STTR Grant to Develop Gene Therapy for Neurofibromatosis Type 2 (NF2)
